Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial - Concepedia

Concepedia

Publication | Open Access

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

DOI Full Paper Access

1.6K

Citations

21

References

2014

Year

Éric Pujade-Lauraine, Felix Hilpert, B. Weber, Andrés Poveda, Gunnar B. Kristensen, Roberto Sorio, Ignace Vergote, Petronella O. Witteveen, Aristotelis Bamias, Deolinda Pereira,

Journal of Clinical Oncology

Abstract

Adding bevacizumab to chemotherapy statistically significantly improved PFS and ORR; the OS trend was not significant. No new safety signals were observed.

References

	Year	Citations

Page 1